EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Immunomodulatory effects of bone marrow-derived Mesenchymal stem cells in a BALB/c mouse model on induced Systemic lupus erythematosus (SLE)

Ghassan Khudhair Esmael, Tarek Rebai, Khalil Gazar Chelab Al-Nailey

Cellular and Molecular Biology · 31.01.2023 · 69 (1) · 19-24

DOI: 10.14715/cmb/2022.69.1.4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular and Molecular Biology, online erschienen am 31.01.2023. Verfasst von Ghassan Khudhair Esmael und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Faculty of Sciences-Sfax, University of Sfax, Tunisia. ghassan.khudhair@qu.edu.iq. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Mesenchymal Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is an autoimmune inflammatory disease that causes acute inflammation in most body tissues. The current study aims to determine levels of some cytokines and chemokines in BALB/c mice with SLE and treatment by using BALB/c Mesenchymal stem cells (BM-MSCs). Forty BALB/c male mice were divided into four groups equally. The first and second groups received activated lymphocyte-derived DNA (ALD DNA) for induction of SLE. The second group received BM-MSCs/IV after the appearance of SLE clinical signs. The third group received BM-MSCs only, while the fourth group (control group) received PBS. All the study groups examine levels of IL-10, IL-6, TGFβ1, VEGF, CCL-2, CCL-5/RANTES, IFNγ, and ICAM -1 by ELISA kits. The cytokines levels are determined in all the study groups. There was a significant increase in ANA and anti-dsDNA levels in the first group, while there was a decrease in the second group (treatment by BM-MSCs). There is no significant difference between the third and control groups in ANA and anti-dsDNA levels. The first group showed a significant increase in IL-6, CCL-5/RANTES, VEGF, ICAM, CCL-2, and IFNγ levels and a decrease in IL-10 and TGFβ1. The second group showed low levels of IL-6, CCL-5/RANTES, VEGF, ICAM, CCL-2/MCP-1, and IFNγ but a high level of IL-10 and TGFβ1 as compared with the control group. The third group has no significant differences from the control group in all the tested parameters. BM-MSCs have an essential therapeutic role in the functional regulation of cytokines and chemokines in mice with SLE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicMesenchymal Stem CellsMaleAnimalsMiceInterleukin-10Bone MarrowMice, Inbred BALB CInterleukin-6Vascular Endothelial Growth Factor ACytokinesDNA

Substanzen

Interleukin-10Interleukin-6Vascular Endothelial Growth Factor ACytokinesDNA

Autor:innen und Institutionen

  • Department of Life Sciences, Faculty of Sciences-Sfax, University of Sfax, Tunisia. ghassan.khudhair@qu.edu.iq.
  • Laboratory Histo-embryology and Cytogenetics, Faculty of Medicine of Sfax, University of Sfax, Tunisia. TarekRebai@gamil.com.
  • University of Al-Qadisiyah, veterinary medicine college - Iraq. KhalilGazar@gmail.com.

Zitieren

APA

Khudhair Esmael, G., Rebai, T., & Gazar Chelab Al-Nailey, K. (2023). Immunomodulatory effects of bone marrow-derived Mesenchymal stem cells in a BALB/c mouse model on induced Systemic lupus erythematosus (SLE). Cellular and Molecular Biology, 69(1), 19-24. https://doi.org/10.14715/cmb/2022.69.1.4

Vancouver

Khudhair Esmael G, Rebai T, Gazar Chelab Al-Nailey K. Immunomodulatory effects of bone marrow-derived Mesenchymal stem cells in a BALB/c mouse model on induced Systemic lupus erythematosus (SLE). Cellular and Molecular Biology. 2023;69(1):19-24. doi:10.14715/cmb/2022.69.1.4

BibTeX
@article{KhudhairEsmael2023,
  author = {Khudhair Esmael, Ghassan and Rebai, Tarek and Gazar Chelab Al-Nailey, Khalil},
  title = {Immunomodulatory effects of bone marrow-derived Mesenchymal stem cells in a BALB/c mouse model on induced Systemic lupus erythematosus (SLE)},
  journal = {Cellular and Molecular Biology},
  year = {2023},
  volume = {69},
  number = {1},
  pages = {19--24},
  doi = {10.14715/cmb/2022.69.1.4}
}
Kostenlos starten →